ArticleClinical rheumatology2022
Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus.
Takehiro Nakai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it